1133 related articles for article (PubMed ID: 17497313)
1. A review of the impact of photon and proton external beam radiotherapy treatment modalities on the dose distribution in field and out-of-field; implications for the long-term morbidity of cancer survivors.
Palm A; Johansson KA
Acta Oncol; 2007; 46(4):462-73. PubMed ID: 17497313
[TBL] [Abstract][Full Text] [Related]
2. Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy.
Mock U; Bogner J; Georg D; Auberger T; Pötter R
Strahlenther Onkol; 2005 Jul; 181(7):448-55. PubMed ID: 15995838
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric advantages of IMPT over IMRT for laser-accelerated proton beams.
Luo W; Li J; Fourkal E; Fan J; Xu X; Chen Z; Jin L; Price R; Ma CM
Phys Med Biol; 2008 Dec; 53(24):7151-66. PubMed ID: 19033641
[TBL] [Abstract][Full Text] [Related]
4. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
[TBL] [Abstract][Full Text] [Related]
5. A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas.
Weber DC; Trofimov AV; Delaney TF; Bortfeld T
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1596-606. PubMed ID: 15050341
[TBL] [Abstract][Full Text] [Related]
6. Intensity-modulated radiation therapy, protons, and the risk of second cancers.
Hall EJ
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):1-7. PubMed ID: 16618572
[TBL] [Abstract][Full Text] [Related]
7. Dose conformation of intensity-modulated stereotactic photon beams, proton beams, and intensity-modulated proton beams for intracranial lesions.
Baumert BG; Norton IA; Lomax AJ; Davis JB
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1314-24. PubMed ID: 15519805
[TBL] [Abstract][Full Text] [Related]
8. Does electron and proton therapy reduce the risk of radiation induced cancer after spinal irradiation for childhood medulloblastoma? A comparative treatment planning study.
Mu X; Björk-Eriksson T; Nill S; Oelfke U; Johansson KA; Gagliardi G; Johansson L; Karlsson M; Zackrisson DB
Acta Oncol; 2005; 44(6):554-62. PubMed ID: 16165914
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
[TBL] [Abstract][Full Text] [Related]
10. Radiation-induced cancers from modern radiotherapy techniques: intensity-modulated radiotherapy versus proton therapy.
Yoon M; Ahn SH; Kim J; Shin DH; Park SY; Lee SB; Shin KH; Cho KH
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1477-85. PubMed ID: 19879701
[TBL] [Abstract][Full Text] [Related]
11. A dosimetric comparison of proton and intensity-modulated photon radiotherapy for pediatric parameningeal rhabdomyosarcomas.
Kozak KR; Adams J; Krejcarek SJ; Tarbell NJ; Yock TI
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):179-86. PubMed ID: 19019562
[TBL] [Abstract][Full Text] [Related]
12. Modelling carcinogenesis after radiotherapy using Poisson statistics: implications for IMRT, protons and ions.
Jones B
J Radiol Prot; 2009 Jun; 29(2A):A143-57. PubMed ID: 19454805
[TBL] [Abstract][Full Text] [Related]
13. The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy.
Kry SF; Salehpour M; Followill DS; Stovall M; Kuban DA; White RA; Rosen II
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1195-203. PubMed ID: 15990025
[TBL] [Abstract][Full Text] [Related]
14. Proton radiotherapy for childhood ependymoma: initial clinical outcomes and dose comparisons.
MacDonald SM; Safai S; Trofimov A; Wolfgang J; Fullerton B; Yeap BY; Bortfeld T; Tarbell NJ; Yock T
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):979-86. PubMed ID: 18325681
[TBL] [Abstract][Full Text] [Related]
15. [IMRT combined to IGRT: increase of the irradiated volume. Consequences?].
Lisbona A; Averbeck D; Supiot S; Delpon G; Ali D; Vinas F; Diana C; Murariu C; Lagrange JL
Cancer Radiother; 2010 Oct; 14(6-7):563-70. PubMed ID: 20729117
[TBL] [Abstract][Full Text] [Related]
16. Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.
Mavroidis P; Ferreira BC; Shi C; Lind BK; Papanikolaou N
Phys Med Biol; 2007 Jul; 52(13):3817-36. PubMed ID: 17664579
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.
Chera BS; Rodriguez C; Morris CG; Louis D; Yeung D; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1173-80. PubMed ID: 19386423
[TBL] [Abstract][Full Text] [Related]
18. Comparison of three different mediastinal radiotherapy techniques in female patients: Impact on heart sparing and dose to the breasts.
Nieder C; Schill S; Kneschaurek P; Molls M
Radiother Oncol; 2007 Mar; 82(3):301-7. PubMed ID: 17156873
[TBL] [Abstract][Full Text] [Related]
19. Dose-volume comparison of proton therapy and intensity-modulated radiotherapy for prostate cancer.
Vargas C; Fryer A; Mahajan C; Indelicato D; Horne D; Chellini A; McKenzie C; Lawlor P; Henderson R; Li Z; Lin L; Olivier K; Keole S
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):744-51. PubMed ID: 17904306
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of movement-induced dose reduction in target volume: a comparison between photon and proton beam treatment.
Yoon M; Shin D; Kwak J; Park S; Lim YK; Kim D; Park SY; Lee SB; Shin KH; Kim TH; Cho KH
Med Dosim; 2009; 34(3):191-201. PubMed ID: 19647628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]